Login / Signup

Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer.

Shota FujiiIsaku OkamotoTakuro OkadaKunihiko TokashikiYuri UedaHiroki SatoTatsuya ItoKiyoaki Tsukahara
Published in: Anticancer research (2024)
The comparison of patient QOL before and after nivolumab use suggested that patient QOL was not compromised. The results were not inferior to those of other studies in terms of treatment efficacy and safety.
Keyphrases
  • case report
  • squamous cell carcinoma
  • small cell lung cancer
  • combination therapy
  • case control
  • replacement therapy